| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 School of Public Health, University of California, Berkeley, California and 2 Division of Occupational and Environmental Medicine, University of California, San Francisco, California
Request for reprints: Craig Steinmaus, Arsenic Health Effects Research Group, School of Public Health, University of California, 140 Warren Hall, Berkeley, CA 94720-7360. Phone: (510) 504-5395; Fax: (510) 843-5539. E-mail: craigs{at}uclink.berkeley.edu
While numerous laboratory investigations have shown that selenium may have anticarcinogenic activity, the epidemiological data have been inconsistent. In this report, meta-analysis was used to quantitatively summarize the existing epidemiological evidence on selenium and lung cancer and identify sources of heterogeneity among studies. When all studies were combined, the summary relative risk (RR) for subjects with higher selenium exposures was 0.74 [95% confidence interval (CI) 0.57–0.97]. In subgroup analyses based on the average selenium level in the study population, the summary RR for areas where selenium levels were low was 0.72 (95% CI 0.45–1.16), while the RR for areas where selenium levels were higher was 0.86 (95% CI 0.61–1.22). In both studies in high selenium areas where RRs were markedly below 1.0, protective effects were only found when subjects in the lowest category of selenium exposure were used as referents. No clear protective effects were seen when highly exposed subjects were compared with those in the middle exposure categories. The summary RR was lower in studies assessing selenium exposure using toenails (RR 0.46, 95% CI 0.24–0.87) than in studies using serum selenium (RR 0.80, 95% CI 0.58–1.10) or studies assessing dietary intake (RR 1.00, 95% CI 0.77–1.30). Overall, these results suggest that selenium may have some protective effect against lung cancer in populations where average selenium levels are low. The evidence for these findings is greater in studies of toenail selenium than in studies involving other measures of exposure.
This article has been cited by other articles:
|
|
 |
|
  C Steinmaus, A H Smith, R M Jones, and M T Smith Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association Occup. Environ. Med., June 1, 2008; 65(6): 371 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bleys, A. Navas-Acien, and E. Guallar Serum Selenium Levels and All-Cause, Cancer, and Cardiovascular Mortality Among US Adults Arch Intern Med, February 25, 2008; 168(4): 404 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mahabir, M. R. Forman, S. L. Barerra, Y. Q. Dong, M. R. Spitz, and Q. Wei Joint Effects of Dietary Trace Metals and DNA Repair Capacity in Lung Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2756 - 2762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chao Associations between Beer, Wine, and Liquor Consumption and Lung Cancer Risk: A Meta-analysis Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2436 - 2447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Alberg, J. G. Ford, and J. M. Samet Epidemiology of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 29S - 55S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gray, J. T. Mao, E. Szabo, M. Kelley, J. Kurie, and G. Bepler Lung Cancer Chemoprevention: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 56S - 68S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Vogt, R. G. Ziegler, B. H. Patterson, and B. I. Graubard Racial Differences in Serum Selenium Concentration: Analysis of US Population Data from the Third National Health and Nutrition Examination Survey Am. J. Epidemiol., August 1, 2007; 166(3): 280 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gao, Y. Jin, K. S. Hall, C. Liang, F. W. Unverzagt, R. Ji, J. R. Murrell, J. Cao, J. Shen, F. Ma, et al. Selenium Level and Cognitive Function in Rural Elderly Chinese Am. J. Epidemiol., April 15, 2007; 165(8): 955 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. BUKALIS, D. ALBER, G. BUKALIS, D. BEHNE, and A. KYRIAKOPOULOS Effects of Selenium Diet on Expression of Selenoproteins in the Lung of the Rat Ann. N.Y. Acad. Sci., January 1, 2007; 1095(1): 467 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. R. Hirsch and S. M. Lippman Advances in the Biology of Lung Cancer Chemoprevention J. Clin. Oncol., May 10, 2005; 23(14): 3186 - 3197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Lippman, P. J. Goodman, E. A. Klein, H. L. Parnes, I. M. Thompson, A. R. Kristal, R. M. Santella, J. L. Probstfield, C. M. Moinpour, D. Albanes, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT) J Natl Cancer Inst, January 19, 2005; 97(2): 94 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Borek Dietary Antioxidants and Human Cancer Integr Cancer Ther, December 1, 2004; 3(4): 333 - 341. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
